Products for Out-Licensing

Products Out-Licensing

NAL develops novel dosage forms and proprietary drug delivery systems based on Company’s captive Drug Delivery System (“DDS”) technologies. NAL expects to partner with pharmaceutical companies for the development and commercialization of the NAL products in global markets.

The partial listing of NAL’s products is outlined below. As we have not disclosed the complete list of our proprietary DDS products under development, please write to us at business@nalpharma.com to know more about NAL’s products and partnering opportunities.

Anti-infectives
 
Products Marketed or Under Development (Partial Listing)
Proposed US Filing
NAL1876 Amphotericin B Liposome Injection for Fungal Infections
ANDA
NAL3210 Antifungal Lacquer for Nail Fungus
505(b)(2) NDA
NAL3220 Antiviral Patch for Shingles
505(b)(2) NDA
Top